Northbound funds are on holiday from today to the 7th due to the National Day holiday. Prior to the long holiday, northbound investors had taken the opportunity to buy heavily, causing the biotech sector to rise against the market trend on Wednesday (30th). However, with U.S. bond risks continuing to escalate, the biotech sector saw profit-taking right at market open today. The biotech sector is currently down over 3.7%, at 16,024 points, with 28 out of the 30 constituent stocks of the biotech index in decline.
Currently, the Hang Seng Index stands at 23,967, down 645 points or 2.6%, with turnover on the main board nearing HK$14.3 billion. The Hang Seng China Enterprises Index is at 8,023, down 196 points or 2.4%. The Hang Seng Tech Index is at 4,145, down 108 points or 2.5%. (am)
| Stock (Code) | Current Price (HK$) | Change (%) |
|---|---|---|
| Innovent Biologics (01801) | 94.2 | Down 3.93% |
| WuXi AppTec (02359) | 206.8 | Down 3.9% |
| China Biologic Products (01177) | 5.605 | Down 1.84% |
| JD Health (06618) | 33.5 | Down 6.94% |
| BeiGene (06160) | 212.6 | Down 5.68% |
| GenScript Biotech (01548) | 43.52 | Down 2.99% |
| WuXi Biologics (02269) | 55.05 | Down 1.78% |
| Insilico Medicine (03696) | 57 | Down 5.16% |
| CSH Group (01093) | 9.955 | Down 1.14% |